Clinical trial
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
NCT00037570 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00037570 |
|---|---|
| Title | Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage |
| Official title | A Randomized Study of the Effect of Intravenous Pantoprazole on Gastric pH After Successful Hemostasis in Patients With Bleeding Peptic Ulcer |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peptic Ulcer Hemorrhage |
| Intervention type | Drug |
| Interventions | Pantoprazole |
| Enrollment | 12 |
| Start date | Nov 1, 2000 |
| Primary completion | Feb 1, 2002 |
| Completion | Feb 1, 2002 |
| First posted | May 20, 2002 |
| Last update posted | Feb 8, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: